{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:14:11Z","timestamp":1790813651357,"version":"4.1.0"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Membranous nephropathy (MN) continues to be a leading cause of nephrotic syndrome in non-diabetic adults. As a unique subtype in the serology-based classification of MN, thrombospondin type 1 domain containing 7A (THSD7A)-associated MN has attracted increasing interest, because, unlike other autoantigens, THSD7A is also expressed in preclinical species, facilitating the study of its role in MN. A heterologous mouse model of THSD7A-associated MN was previously established using a proprietary in-house antibody that was unfortunately not available to the research community. Here, we developed a mouse model of THSD7A-associated MN by administering a commercially available antibody targeting the most N-terminal part of THSD7A. Our model was characterized by heavy proteinuria and pathological features of human MN without sex differences. Complement depletion with cobra venom factor only partially attenuated proteinuria and glomerular injury in this model, entailing that complement-independent pathomechanisms also contribute. Consistently, <jats:italic>in vitro<\/jats:italic> in primary podocytes, exposure to the anti-THSD7A antibody caused evident podocytopathic changes, including disruption of actin cytoskeleton integrity, podocyte hypermobility, oxidative stress, and apoptotic cell death. These signs of podocytopathy were preserved, albeit to a lesser extent, after complement inactivation, indicating autonomous podocyte injury. Furthermore, as the first FDA-approved treatment for primary MN, adrenocorticotropic hormone therapy with repository corticotropin injection (Purified Cortrophin Gel<jats:sup>\u00ae<\/jats:sup>) appeared to be beneficial and significantly attenuated proteinuria and glomerular injury, suggesting that this model may be useful for developing novel treatments or understanding the pathogenesis of MN. Collectively, our model, based on the use of a commercially available anti-THSD7A antibody, will be an important tool for MN research.<\/jats:p>","DOI":"10.3389\/fphar.2024.1430451","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T05:04:18Z","timestamp":1721192658000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["THSD7A-associated membranous nephropathy involves both complement-mediated and autonomous podocyte injury"],"prefix":"10.3389","volume":"15","author":[{"given":"Jing","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Gunning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance","family":"Dworkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rujun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ekir.2020.11.032","article-title":"Establishing a case for anti-complement therapy in membranous nephropathy","volume":"6","author":"Ayoub","year":"2021","journal-title":"Kidney Int. Rep."},{"key":"B2","first-page":"185","article-title":"Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats","volume":"135","author":"Baker","year":"1989","journal-title":"Am. J. Pathol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/ki.2014.428","article-title":"Fine-tuning of NF\u03baB by glycogen synthase kinase 3\u03b2 directs the fate of glomerular podocytes upon injury","volume":"87","author":"Bao","year":"2015","journal-title":"Kidney Int."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1681\/ASN.2017020178","article-title":"PLA2R and THSD7A: disparate paths to the same disease?","volume":"28","author":"Beck","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"143274","DOI":"10.1155\/2014\/143274","article-title":"Antiphospholipase A\u2082 receptor autoantibodies: a comparison of three different immunoassays for the diagnosis of idiopathic membranous nephropathy","volume":"2014","author":"Behnert","year":"2014","journal-title":"J. Immunol. Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1681\/ASN.0000000000000062","article-title":"Podocyte geranylgeranyl transferase type-I is essential for maintenance of the glomerular filtration barrier","volume":"34","author":"Boi","year":"2023","journal-title":"J. Am. Soc. Nephrol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1681\/ASN.2005010028","article-title":"Management of membranous nephropathy: when and what for treatment","volume":"16","author":"Cattran","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1681\/ASN.2022050605","article-title":"Negative modulation of B cell activation by melanocortin 1 receptor signaling protects against membranous nephropathy","volume":"34","author":"Chen","year":"2023","journal-title":"J. Am. Soc. Nephrol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2215\/CJN.11761116","article-title":"Primary membranous nephropathy","volume":"12","author":"Couser","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e104936","DOI":"10.1371\/journal.pone.0104936","article-title":"The diagnosis accuracy of PLA2R-AB in the diagnosis of idiopathic membranous nephropathy: a meta-analysis","volume":"9","author":"Du","year":"2014","journal-title":"PLoS One"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e141848","DOI":"10.1172\/JCI141848","article-title":"Age-related GSK3\u03b2 overexpression drives podocyte senescence and glomerular aging","volume":"132","author":"Fang","year":"2022","journal-title":"J. Clin. Invest."},{"key":"B13","doi-asserted-by":"publisher","first-page":"12827","DOI":"10.3390\/ijms222312827","article-title":"The MTT assay: utility, limitations, pitfalls, and interpretation in bulk and single-cell analysis","volume":"22","author":"Ghasemi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1056\/NEJMc1500130","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"372","author":"Godel","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1093\/ndt\/gfx235","article-title":"Glomerular mannose-binding lectin deposition in intrinsic antigen-related membranous nephropathy","volume":"33","author":"Hayashi","year":"2018","journal-title":"Nephrol. Dial. Transpl."},{"key":"B16","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1681\/ASN.2018090941","article-title":"Thrombospondin type 1 domain-containing 7A localizes to the slit diaphragm and stabilizes membrane dynamics of fully differentiated podocytes","volume":"30","author":"Herwig","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41581-022-00564-1","article-title":"Membranous nephropathy: new pathogenic mechanisms and their clinical implications","volume":"18","author":"Hoxha","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e13855","DOI":"10.1111\/ijcp.13855","article-title":"Renal expression of PLA2R, THSD7A, and IgG4 in patients with membranous nephropathy and correlation with clinical findings","volume":"75","author":"Kaya","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"B19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.kint.2023.10.035","article-title":"Complement activation and effector pathways in membranous nephropathy","volume":"105","author":"Kistler","year":"2024","journal-title":"Kidney Int."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1097\/01.asn.0000078803.53165.c9","article-title":"Expression of podocyte-associated molecules in acquired human kidney diseases","volume":"14","author":"Koop","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1038\/ki.1995.224","article-title":"Active Heymann nephritis in complement component C6 deficient rats","volume":"47","author":"Leenaerts","year":"1995","journal-title":"Kidney Int."},{"key":"B22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/path.4692","article-title":"The \u03b2 isoform of GSK3 mediates podocyte autonomous injury in proteinuric glomerulopathy","volume":"239","author":"Li","year":"2016","journal-title":"J. Pathol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12929-016-0277-9","article-title":"Motor neuron-derived Thsd7a is essential for zebrafish vascular development via the Notch-dll4 signaling pathway","volume":"23","author":"Liu","year":"2016","journal-title":"J. Biomed. Sci."},{"key":"B24","doi-asserted-by":"publisher","first-page":"952235","DOI":"10.3389\/fimmu.2022.952235","article-title":"The alternative pathway is necessary and sufficient for complement activation by anti-thsd7a autoantibodies, which are predominantly IgG4 in membranous nephropathy","volume":"13","author":"Manral","year":"2022","journal-title":"Front. Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1056\/NEJMc1500130","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"372","author":"Meyer-Schwesinger","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B26","first-page":"121","article-title":"Membrane attack complex deposition in experimental glomerular injury","volume":"120","author":"Perkinson","year":"1985","journal-title":"Am. J. Pathol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1172\/JCI15645","article-title":"DNA damage is a novel response to sublytic complement C5b-9-induced injury in podocytes","volume":"111","author":"Pippin","year":"2003","journal-title":"J. Clin. Invest."},{"key":"B28","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1681\/ASN.2008121259","article-title":"Autoimmunity in membranous nephropathy targets aldose reductase and SOD2","volume":"21","author":"Prunotto","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ekir.2017.09.001","article-title":"Temporal association between PLA2R antibodies and clinical outcomes in primary membranous nephropathy","volume":"3","author":"Ramachandran","year":"2018","journal-title":"Kidney Int. Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1016\/j.celrep.2018.04.059","article-title":"A multi-layered quantitative in vivo expression atlas of the podocyte unravels kidney disease candidate genes","volume":"23","author":"Rinschen","year":"2018","journal-title":"Cell Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-021-00303-z","article-title":"Membranous nephropathy","volume":"7","author":"Ronco","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1681\/ASN.2014070640","article-title":"Anti-phospholipase A2 receptor antibody titer predicts post-rituximab outcome of membranous nephropathy","volume":"26","author":"Ruggenenti","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1172\/JCI109987","article-title":"A new role for complement in experimental membranous nephropathy in rats","volume":"66","author":"Salant","year":"1980","journal-title":"J. Clin. Invest."},{"key":"B34","doi-asserted-by":"publisher","first-page":"7926","DOI":"10.1073\/pnas.1820892116","article-title":"Small-molecule factor B inhibitor for the treatment of complement-mediated diseases","volume":"116","author":"Schubart","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1681\/ASN.2017070805","article-title":"The most N-terminal region of THSD7A is the predominant target for autoimmunity in thsd7a-associated membranous nephropathy","volume":"29","author":"Seifert","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41467-023-36068-0","article-title":"The classical pathway triggers pathogenic complement activation in membranous nephropathy","volume":"14","author":"Seifert","year":"2023","journal-title":"Nat. Commun."},{"key":"B37","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.kint.2019.09.014","article-title":"Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy","volume":"97","author":"Sethi","year":"","journal-title":"Kidney Int."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.kint.2020.05.030","article-title":"Semaphorin 3B-associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients","volume":"98","author":"Sethi","year":"","journal-title":"Kidney Int."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1681\/ASN.2020081165","article-title":"Protocadherin 7-associated membranous nephropathy","volume":"32","author":"Sethi","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"172","DOI":"10.4049\/jimmunol.179.1.172","article-title":"Induction of passive Heymann nephritis in complement component 6-deficient PVG rats","volume":"179","author":"Spicer","year":"2007","journal-title":"J. Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1016\/S0002-9440(10)65080-8","article-title":"Complement C5b-9-mediated arachidonic acid metabolism in glomerular epithelial cells: role of cyclooxygenase-1 and -2","volume":"156","author":"Takano","year":"2000","journal-title":"Am. J. Pathol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/s0161-5890(96)00078-8","article-title":"Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv","volume":"33","author":"Thomas","year":"1996","journal-title":"Mol. Immunol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"371","author":"Tomas","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1172\/JCI85265","article-title":"Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy","volume":"126","author":"Tomas","year":"2016","journal-title":"J. Clin. Invest."},{"key":"B45","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1681\/ASN.2017010030","article-title":"A heterologous model of thrombospondin type 1 domain-containing 7A-associated membranous nephropathy","volume":"28","author":"Tomas","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: from structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front. Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/jcp.21990","article-title":"Thrombospondin type I domain containing 7A (THSD7A) mediates endothelial cell migration and tube formation","volume":"222","author":"Wang","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20180131","article-title":"Human anti-thrombospondin type 1 domain-containing 7A antibodies induce membranous nephropathy through activation of lectin complement pathway","volume":"38","author":"Wang","year":"2018","journal-title":"Biosci. Rep."},{"key":"B49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1681\/ASN.2018090912","article-title":"Advantages of single-nucleus over single-cell RNA sequencing of adult kidney: rare cell types and novel cell States revealed in fibrosis","volume":"30","author":"Wu","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1016\/j.ajpath.2014.06.027","article-title":"Glycogen synthase kinase 3\u03b2 dictates podocyte motility and focal adhesion turnover by modulating paxillin activity: implications for the protective effect of low-dose lithium in podocytopathy","volume":"184","author":"Xu","year":"2014","journal-title":"Am. J. Pathol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1159\/000508665","article-title":"Effect of glomerular mannose-binding lectin deposition on the prognosis of idiopathic membranous nephropathy","volume":"45","author":"Zhang","year":"2020","journal-title":"Kidney Blood Press Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1016\/j.ajpath.2011.01.029","article-title":"Mitochondrial dysfunction mediates aldosterone-induced podocyte damage: a therapeutic target of PPAR\u03b3","volume":"178","author":"Zhu","year":"2011","journal-title":"Am. J. Pathol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1430451\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T05:04:23Z","timestamp":1721192663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1430451\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,17]]},"references-count":52,"alternative-id":["10.3389\/fphar.2024.1430451"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1430451","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,17]]},"article-number":"1430451"}}